Search Results

Filter
  • 1-10 of  209 results for ""Lymphoma, Follicular""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Differential tumor protein expression at follicular lymphoma diagnosis reveals dysregulation of key molecular pathways associated with histological transformation.

  • Authors : Enemark MH; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/pathology ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/metabolism ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/diagnosis

  • Source: Scientific reports [Sci Rep] 2024 Dec 02; Vol. 14 (1), pp. 29962. Date of Electronic Publication: 2024 Dec 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Changes of T cell subsets across treatments associated with prognosis in newly diagnosed follicular lymphoma.

  • Authors : Jiang Q; Department of Hematology, Institute of Hematology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, China.; Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, Fujian Province, China.

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/immunology ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/diagnosis ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/drug therapy

  • Source: Scientific reports [Sci Rep] 2024 Nov 11; Vol. 14 (1), pp. 27576. Date of Electronic Publication: 2024 Nov 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Recent advances in treatment of follicular lymphoma: efficacy of PI3Kα/δ inhibitor (TQ-B3525).

  • Authors : Watanabe T; Department of Internal Medicine and Gastroenterology, Watanabe Internal Medicine Aoyama Clinic, Niigata-city, 9502002, Japan. .

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/drug therapy ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/genetics ; Phosphoinositide-3 Kinase Inhibitors*/Phosphoinositide-3 Kinase Inhibitors*/Phosphoinositide-3 Kinase Inhibitors*/therapeutic use

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 May 16; Vol. 9 (1), pp. 134. Date of Electronic Publication: 2024 May 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited

Record details

×
Academic Journal

Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.

  • Authors : Wang H; Department of Oncology, Tianjin Union Medical Center of Nankai University, Tianjin, 300121, PR China.; The Institute of Translational Medicine, Tianjin Union Medical Center of Nankai University, Tianjin, 300121, PR China.

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/drug therapy ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/genetics; Humans

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Apr 17; Vol. 9 (1), pp. 99. Date of Electronic Publication: 2024 Apr 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited

Record details

×
Academic Journal

Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.

Subjects: Positron Emission Tomography Computed Tomography*/Positron Emission Tomography Computed Tomography*/Positron Emission Tomography Computed Tomography*/methods ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/diagnostic imaging; Humans

  • Source: Scientific reports [Sci Rep] 2024 Apr 05; Vol. 14 (1), pp. 8033. Date of Electronic Publication: 2024 Apr 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms.

  • Authors : Fernández-Garnacho EM; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.; Nadeu F

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/pathology ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/genetics ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics

  • Source: Scientific reports [Sci Rep] 2023 Oct 06; Vol. 13 (1), pp. 16839. Date of Electronic Publication: 2023 Oct 06.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy.

  • Authors : Iwamuro M; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, Okayama, 700-8558, Japan. .; Tanaka T

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/pathology; Humans ; Retrospective Studies

  • Source: Scientific reports [Sci Rep] 2023 Apr 11; Vol. 13 (1), pp. 5858. Date of Electronic Publication: 2023 Apr 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial.

  • Authors : Ying Z; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China.; Xie Y

Subjects: Receptors, Chimeric Antigen* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/therapy ; Lymphoma, Follicular*

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2023 Mar; Vol. 58 (3), pp. 288-294. Date of Electronic Publication: 2022 Dec 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

NMR-based metabolomic profiling can differentiate follicular lymphoma from benign lymph node tissues and may be predictive of outcome.

  • Authors : Banoei MM; Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Mahé E

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/diagnosis; Aged ; Humans

  • Source: Scientific reports [Sci Rep] 2022 May 18; Vol. 12 (1), pp. 8294. Date of Electronic Publication: 2022 May 18.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders.

  • Authors : Jønsson V; Department of Hematology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Nydalen, P.O. box 4950, 0424, Oslo, Norway. .; Awan H

Subjects: Leukemia*/Leukemia*/Leukemia*/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/pathology ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/pathology

  • Source: Scientific reports [Sci Rep] 2022 Apr 12; Vol. 12 (1), pp. 6138. Date of Electronic Publication: 2022 Apr 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
  • 1-10 of  209 results for ""Lymphoma, Follicular""